content

Artificial DNA can control release of active ingredients from drugs

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical...

SpringWorks and GSK sign clinical trial collaboration agreement

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKlineโ€™s (GSK) belantamab mafodotin to treat patients with relapsed or refractory...

Velabs Therapeutics Announces 3 Million Series B Financing to Advance its Functional Antibody Screening Programme

Velabs Therapeutics GmbH, a leader in rapid screening of functional therapeutic antibodies, announced the closing of a โ‚ฌ3 million Series B financing round to...

AbbVie Announces US FDA Lifts Partial Clinical Hold on Phase 3 Study of Venetoclax in Patients with Multiple Myeloma Positive for the Genetic Abnormality

AbbVie , a research-based global biopharmaceutical company announced that the U.S. FDAย  has lifted the partial clinical hold placed on CANOVA (M13-494), a Phase...

CPhI series reporting successful first half to 2019

The CPhI global pharma event series โ€“ part of Informa Marketโ€™s Health & Nutrition business โ€“ continues to surge ahead in 2019 with its...

Parexel Strengthens Risk-Based Monitoring Offering with CluePointsโ€™ New Advanced Statistical Capabilities

Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the worldโ€™s health. ...

Concept Life Sciences Opens New Facility to Offer Complete Pharmaceutical Manufacturing Support Services

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, has unveiled a new, state-of-the-art clinical and niche commercial facility to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read